 |
methotrexate oral solution |
|---|---|
| Trade Name | Xatmep |
| Orphan Indication | Oligoarticular juvenile idiopathic arthritis (persistent oligoarthritis, psoriatic juvenile idiopathic arthritis, enthesitis-related arthritis, or undifferentiated arthritis) and polyarticular juvenile idiopathic arthritis in children 0 through 16 years of age |
| USA Market Approval | USA |
| USA Designation Date | 2015-08-27 00:00:00 |
| Sponsor | Silvergate Pharmaeuticals, Inc.;6251 Greenwood Plaza Blvd, Suite 101;Greenwood Village, Colorado, 80111 |
